Form 4: Tenet Healthcare CEO's RSU Vesting & Tax Withholding
Insider Transaction Report
Tenet Healthcare CEO Saumya Sutaria reported the vesting of restricted stock units and subsequent tax-related share disposition on December 31, 2025.
Summary
- Saumya Sutaria, CEO and Director of Tenet Healthcare Corp (THC), reported transactions related to her beneficial ownership.
- On December 31, 2025, 13,016 restricted stock units (RSUs) vested and converted into common stock on a one-for-one basis.
- Concurrently, 6,610 shares of common stock were disposed of to cover tax obligations upon the vesting of these RSUs.
- The shares disposed for tax purposes were valued at $198.72 per share, representing the closing price of the common stock on December 31, 2025.
- Following these transactions, Sutaria directly beneficially owns 375,089 shares of common stock.
- Sutaria also beneficially owns 39,049 derivative securities in the form of restricted stock units.
- The RSUs were granted on January 23, 2025, under the 2019 Stock Incentive Plan and vest in equal 1/4 increments annually.
Sentiment
Score: 5
Explanation: The filing reports a routine, pre-scheduled insider transaction involving the vesting of restricted stock units and subsequent tax withholding, which is a normal compensation event and does not indicate a significant positive or negative shift in company performance or outlook.
Positives
- The vesting of restricted stock units represents a scheduled compensation event for the CEO, indicating the execution of long-term incentive plans.
- The acquisition of 13,016 shares of common stock increases the CEO's direct equity stake in the company, aligning her interests with shareholders.
Negatives
- The disposition of 6,610 shares for tax withholding is a routine and expected event associated with RSU vesting and does not reflect a negative outlook on the company.
Future Outlook
The remaining 3/4 increments of the restricted stock units granted on January 23, 2025, are scheduled to vest equally on December 31, 2026, 2027, and 2028.
Industry Context
This filing reports a routine insider compensation event for a healthcare services company. Such transactions are common across industries as part of executive compensation packages designed to align management incentives with long-term shareholder value.
Stakeholder Impact
- Shareholders: The CEO's increased direct ownership through RSU vesting generally aligns management interests with shareholder value. The tax-related disposition is a standard part of executive compensation.
Next Steps
- Future vesting of the remaining restricted stock units on December 31, 2026, 2027, and 2028.
Key Dates
| Date | Description |
|---|---|
| January 23, 2025 | Restricted stock units were granted pursuant to the 2019 Stock Incentive Plan. |
| December 31, 2025 | First 1/4 increment of restricted stock units vested, leading to the acquisition of common stock and disposition of shares for tax withholding. |
| December 31, 2026 | Scheduled vesting date for the next 1/4 increment of restricted stock units. |
| December 31, 2027 | Scheduled vesting date for the next 1/4 increment of restricted stock units. |
| December 31, 2028 | Scheduled vesting date for the final 1/4 increment of restricted stock units. |
| January 2, 2026 | Date the Form 4 was signed by the reporting person's attorney-in-fact. |
Keywords
Tenet Healthcare, THC, Saumya Sutaria, Restricted Stock Units, RSU vesting, Insider transaction, Form 4, Stock compensation, Tax withholding, Beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.